Creative Medical Technology

CELZNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$9.361 M

$1.42 +23.48%

Close of 7 Aug 2026

Revenue

$6.00K

#3651 by revenue

Earnings

-$6.00M

Loss-making

Shares outstanding

6,592,557

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#147Senti BiosciencesSNTI$11.0M
#148In8bioINAB$9.64M
#149Creative Medical TechnologyCELZ$9.36M
#150AIM ImmunoTechAIM$7.91M
#151VivoSim LabsVIVS$7.85M

Where these numbers come from

Share counts and financials for Creative Medical Technology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.